SE9701010D0 - Antibody - Google Patents

Antibody

Info

Publication number
SE9701010D0
SE9701010D0 SE9701010A SE9701010A SE9701010D0 SE 9701010 D0 SE9701010 D0 SE 9701010D0 SE 9701010 A SE9701010 A SE 9701010A SE 9701010 A SE9701010 A SE 9701010A SE 9701010 D0 SE9701010 D0 SE 9701010D0
Authority
SE
Sweden
Prior art keywords
antibody
receptor
conformation
inactive
growth hormone
Prior art date
Application number
SE9701010A
Other languages
English (en)
Swedish (sv)
Inventor
Jose Mario Mellado Garcia
Jose Miguel Rodriguez Frade
Leonor Kremer Baron
Carlos Martinez Alonso
Original Assignee
Pharmacia & Upjohn Ab
Consejo Superior Investigacion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab, Consejo Superior Investigacion filed Critical Pharmacia & Upjohn Ab
Priority to SE9701010A priority Critical patent/SE9701010D0/xx
Publication of SE9701010D0 publication Critical patent/SE9701010D0/xx
Priority to JP54044798A priority patent/JP2001524816A/ja
Priority to AU65304/98A priority patent/AU739758B2/en
Priority to CA002285036A priority patent/CA2285036A1/en
Priority to DE69825583T priority patent/DE69825583T2/de
Priority to PCT/SE1998/000496 priority patent/WO1998041872A1/en
Priority to PT98911331T priority patent/PT979410E/pt
Priority to US09/044,154 priority patent/US6645723B2/en
Priority to AT98911331T priority patent/ATE273514T1/de
Priority to EP98911331A priority patent/EP0979410B1/de
Priority to DK98911331T priority patent/DK0979410T3/da
Priority to ES98911331T priority patent/ES2224367T3/es
Priority to NZ337636A priority patent/NZ337636A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2869—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/61—Growth hormones [GH] (Somatotropin)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/715—Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
SE9701010A 1997-03-19 1997-03-19 Antibody SE9701010D0 (sv)

Priority Applications (13)

Application Number Priority Date Filing Date Title
SE9701010A SE9701010D0 (sv) 1997-03-19 1997-03-19 Antibody
NZ337636A NZ337636A (en) 1997-03-19 1998-03-19 Method for determining cytokine receptor activation by the use of an antibody
DE69825583T DE69825583T2 (de) 1997-03-19 1998-03-19 Methode zum bestimmen der aktivierung von zytokinrezeptoren mit hilfe eines antikörpers
AU65304/98A AU739758B2 (en) 1997-03-19 1998-03-19 Method for determining cytokine receptor activation by the use of an antibody
CA002285036A CA2285036A1 (en) 1997-03-19 1998-03-19 Method for determining cytokine receptor activation by the use of an antibody
JP54044798A JP2001524816A (ja) 1997-03-19 1998-03-19 抗体の使用によるサイトカイン受容体活性化の測定方法
PCT/SE1998/000496 WO1998041872A1 (en) 1997-03-19 1998-03-19 Method for determining cytokine receptor activation by the use of an antibody
PT98911331T PT979410E (pt) 1997-03-19 1998-03-19 Metodo para a determinacao da activacao de receptor para citocina pelo uso de umanticorpo
US09/044,154 US6645723B2 (en) 1997-03-19 1998-03-19 Method for determining cytokine receptor activation by the use of an antibody
AT98911331T ATE273514T1 (de) 1997-03-19 1998-03-19 Methode zum bestimmen der aktivierung von zytokinrezeptoren mit hilfe eines antikörpers
EP98911331A EP0979410B1 (de) 1997-03-19 1998-03-19 Methode zum bestimmen der aktivierung von zytokinrezeptoren mit hilfe eines antikörpers
DK98911331T DK0979410T3 (da) 1997-03-19 1998-03-19 Fremgangsmåde til bestemmelse af cytokinreceptoraktivering ved anvendelse af et antistof
ES98911331T ES2224367T3 (es) 1997-03-19 1998-03-19 Procedimiento para determinar la activacion del receptor de citocinas mediante el uso de un anticuerpo.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9701010A SE9701010D0 (sv) 1997-03-19 1997-03-19 Antibody

Publications (1)

Publication Number Publication Date
SE9701010D0 true SE9701010D0 (sv) 1997-03-19

Family

ID=20406234

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9701010A SE9701010D0 (sv) 1997-03-19 1997-03-19 Antibody

Country Status (13)

Country Link
US (1) US6645723B2 (de)
EP (1) EP0979410B1 (de)
JP (1) JP2001524816A (de)
AT (1) ATE273514T1 (de)
AU (1) AU739758B2 (de)
CA (1) CA2285036A1 (de)
DE (1) DE69825583T2 (de)
DK (1) DK0979410T3 (de)
ES (1) ES2224367T3 (de)
NZ (1) NZ337636A (de)
PT (1) PT979410E (de)
SE (1) SE9701010D0 (de)
WO (1) WO1998041872A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6821738B2 (en) 1999-01-20 2004-11-23 The Board Of Regents For Oklahoma State University Broad spectrum bio-detection of nerve agents, organophosphates, and other chemical warfare agents
GB9904395D0 (en) * 1999-02-25 1999-04-21 Fluorescience Ltd Protein assay
US6972198B2 (en) * 1999-02-26 2005-12-06 Cyclacel, Ltd. Methods and compositions using protein binding partners
DE10306992A1 (de) * 2003-02-19 2005-08-11 Klinikum der Universität München Großhadern-Innenstadt Verfahren zur quantitativen Messung von Liganden in der Probe gelöster Bindungsproteine
SE0301917D0 (sv) 2003-06-30 2003-06-30 Biovitrum Ab Methods for identifying active compounds
JP2005325055A (ja) * 2004-05-14 2005-11-24 Peptide Door Co Ltd リガンド結合タンパク質含有複合体及びリガンド結合タンパク質に結合する物質のスクリーニング方法
JP6930916B2 (ja) * 2015-02-12 2021-09-01 ユニヴァーシティ オブ サザン カリフォルニアＵｎｉｖｅｒｓｉｔｙ ｏｆ Ｓｏｕｔｈｅｒｎ Ｃａｌｉｆｏｒｎｉａ 疾患予防および治療における成長ホルモン受容体の遮断剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593844A (en) 1990-11-19 1997-01-14 Genentech, Inc. Ligand-mediated immunofunctional hormone binding protein assay method
JP3417558B2 (ja) 1991-05-10 2003-06-16 ジェネンテク，インコーポレイテッド 配位子作用薬および拮抗薬の選択
WO1993021230A1 (en) * 1992-04-10 1993-10-28 Dana-Farber Cancer Institute, Inc. Activation-state-specific phosphoprotein immunodetection
US5470952A (en) * 1993-10-20 1995-11-28 Regeneron Pharmaceuticals, Inc. CNTF and IL-6 antagonists

Also Published As

Publication number Publication date
AU6530498A (en) 1998-10-12
NZ337636A (en) 2001-06-29
US6645723B2 (en) 2003-11-11
DK0979410T3 (da) 2004-11-22
AU739758B2 (en) 2001-10-18
ES2224367T3 (es) 2005-03-01
ATE273514T1 (de) 2004-08-15
EP0979410B1 (de) 2004-08-11
JP2001524816A (ja) 2001-12-04
DE69825583D1 (de) 2004-09-16
CA2285036A1 (en) 1998-09-24
PT979410E (pt) 2004-11-30
DE69825583T2 (de) 2005-08-11
EP0979410A1 (de) 2000-02-16
US20030077663A1 (en) 2003-04-24
WO1998041872A1 (en) 1998-09-24

Similar Documents

Publication Publication Date Title
DE69822484D1 (de) Methoden zur bestimmung der rezeptoraktivität und dafür verwendbare konstrukte
DK0964874T3 (da) CAML-bindende lymfocytoverfladereceptor, nukleinsyrer, som koder derfor, og fremgangsmåder til anvendelse deraf
DK0943097T3 (da) Fremgangsmåde til at påvise IgE
IL101233A (en) Receptor-based screening and identifying methods for amylin agonists and antagonists
ATE193553T1 (de) Domänen von extrazellulären bereichen von menschlichen blutplättchen abstammenden wachstumsfaktor rezeptor-polypeptiden
NO983431L (no) Anti-klöemidler
IS2508B (is) Mótefni gegn ED-B hneppinu í fíbrónektíni, smíði þeirra og notkanir
IL139163A0 (en) A method of predicting the ability of compounds to modulate the biological activity of receptors
DK1141237T3 (da) PTH-receptor og screeningsassay der anvender denne
SE9701010D0 (sv) Antibody
ATE300611T1 (de) Auf rezeptorgrundlage arbeitende screening- verfahren für protein wechselwirkungen
ZA912303B (en) Protein partner screening assays and uses thereof
GB0126319D0 (en) Microfluidic serrs detection
ATE284955T1 (de) Map-kinase: polypeptide, polynukleotide und ihre verwendung
AU2002210982A1 (en) Method of screening antiplatelet
WO1998002455A3 (en) Transcriptional intermediary factor-2 (tfif2)
DE69606024D1 (de) Feststellung von antikörperproduktion
DK1224222T3 (da) Chemokinreceptor
DK1317564T3 (da) Screeningsfremgangsmåder til at identificere G-proteiner og andre forbindelser, som modulerer phosphodiesterase (PDE)-aktiviteten
DK0958351T3 (da) Chimere målmolekyler med regulerbar aktivitet
WO2001065262A3 (en) Reagents and methods useful for detecting diseases of the breast
ATE305508T1 (de) Denervierende muskelkinase (dmk), ein rezeptor der tyrosinkinase-superfamilie
ATE301833T1 (de) Verfahren zum screenen einer die oligomerisierung von rezeptorproteinmolekülen fördernden substanz
ES2167906T3 (es) Nuevo procedimiento de analisis de los receptores plaquetarios gpiib/iiia.
CA2366277A1 (fr) Famille des proteines grb7 et le recepteur de l'insuline pour le criblage de nouveaux medicaments